Skip to main content

D. E. Shaw & Co., Inc.

Position in GRAL — GRAIL, Inc.

CIK 1009207 New York, NY

Position in GRAL

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,217,397
+$769,833 QoQ
Shares Held
81,606
+102.6% QoQ
Ownership
0.190%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in GRAL Over Time

Shares Held

Position Value (USD)

Derivatives in GRAL

reported options exposure · as of Mar 31, 2026
CallValue
$496,128
CallShares
9,600
PutValue
$2,325,600
PutShares
45,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $1,676,976,764 across 27 Diagnostics & Research names. GRAL ranks #19 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GRAL

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,325,600 45,000
2026-03-31 $496,128 9,600
2026-03-31 $4,217,397 81,606
2025-12-31 $3,447,564 40,280
2025-12-31 $4,330,854 50,600
2025-12-31 $10,279,359 120,100
2025-09-30 $2,334,451 39,480
2025-09-30 $4,819,095 81,500
2025-09-30 $331,128 5,600
2025-06-30 $287,952 5,600
2025-06-30 $6,988,645 135,913
2025-06-30 $3,892,494 75,700
2025-03-31 $6,851,922 268,282
2025-03-31 $615,514 24,100
2024-12-31 $288,456 16,160
2024-09-30 $229,626 16,688
2024-06-30 $292,890 19,056
2024-06-30 $1,059,085 68,906